Free Trial
NASDAQ:LFST

LifeStance Health Group Q3 2026 Earnings Date & Estimates

LifeStance Health Group logo
$12.36 +0.31 (+2.53%)
As of 01:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeStance Health Group is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from LifeStance Health Group in Q3 2026

LifeStance Health Group is expected to post earnings of $0.0369 per share on revenue of $431.60 million. In the same quarter a year earlier LifeStance Health Group reported $0.0207 per share on revenue of $363.81 million. LifeStance Health Group last reported on August 6, 2026, posting $0.06 per share and beating the $0.0328 consensus estimate. LifeStance Health Group has beaten the consensus EPS estimate in 7 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.0369
Expected Revenue
$431.60 million
Prior-Year EPS
$0.0207
Prior-Year Revenue
$363.81 million
Expected EPS Growth
+77.8%
Expected Revenue Growth
+18.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.06 (Beat by +$0.0273)
Last Quarter Revenue
$435.35 million
EPS Beat Rate
7 of last 8 quarters

LifeStance Health Group Q3 2026 Earnings FAQ

LifeStance Health Group (NASDAQ:LFST) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens.

LifeStance Health Group's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect LifeStance Health Group to post earnings of $0.0369 per share for Q3 2026.

The consensus revenue estimate for LifeStance Health Group is $431.60 million for Q3 2026.

LifeStance Health Group Earnings Headlines

Contrasting LifeStance Health Group (NASDAQ:LFST) & PACS Group (NYSE:PACS)
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More LifeStance Health Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like LifeStance Health Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LifeStance Health Group and other key companies, straight to your email.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services. The company was founded in 2017 and became a publicly traded company on the Nasdaq in 2021. Its leadership includes Chief Executive Officer Danish Qureshi, who has overseen the company’s efforts to expand access to coordinated mental healthcare.

View LifeStance Health Group Profile